Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000035

President and CEO sold 17,483 shares at $19.43 ($339,695)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-05 Sale : show line 1 in the form −17,483 $19.43 $339,695 2,276,181 I
Open-market sales · 17,483 sh · avg $19.43 · $339,695
Loading xslF345X05/wk-form4_1704846791.xml…